Synopsis Trachoma is the leading infection-initiated cause of blindness in the world. Fluorometholone 0.1%, is a low-cost generic drug approved for the ocular inflammation. Thus the present study aimed to assess the safety and efficacy of fluorometholone 0.1% eye drops for trachomatous trichiasis (TT) surgery. This week’s “MED FACT” discusses a clinical trial from American Journal of Ophthalmology, “Fluorometholone 0.1% as Ancillary Therapy for Trachomatous Trichiasis Surgery: Randomized Clinical Trial”. Authors: John H.
Kempen et. al. Key Takeaways Fluorometholone 0.1% is likely to be safe and efficacious to reduce post-op TT following TT surgery. Objective: To assess the hypothesis that fluorometholone 0.1% eye drops are safe and effective as adjunctive therapy for trachomatous trichiasis (TT) surgery Study Type: Randomized, placebo-controlled, double-masked parallel dose-ranging…
